• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-205在前列腺癌中经常下调,并通过抑制肿瘤生长发挥肿瘤抑制作用。

miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.

作者信息

Wang Ning, Li Qi, Feng Ning-Han, Cheng Gong, Guan Zhao-Long, Wang Yang, Qin Chao, Yin Chang-Jun, Hua Li-Xin

出版信息

Asian J Androl. 2013 Nov;15(6):735-41. doi: 10.1038/aja.2013.80. Epub 2013 Aug 26.

DOI:10.1038/aja.2013.80
PMID:23974361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3854052/
Abstract

The purpose of this study was to elucidate the molecular mechanisms of microRNA-205 (miR-205) as a tumor suppressor in prostate cancer (PCa). In the present study, microRNA microarray analysis suggested that the expression of miR-205 was significantly decreased in advanced PCa compared with early PCa. Real-time PCR analysis also indicated that miR-205 expression was significantly decreased in PCa tissues compared with non-cancerous tissues. Moreover, the expression of miR-205 has been demonstrated to be associated with the clinicopathological stage and total/free prostate-specific antigen (PSA) level of PCa. Functional analyses showed that both the overexpression of miR-205 and the knockdown of c-SRC in PCa cell lines could inhibit cell growth, colony formation, migration, invasion and the cell cycle as well as induce cell apoptosis in vitro. Furthermore, over-expressing miR-205 reduced tumorigenicity in vivo. Through a luciferase activity assay and Western blotting, c-SRC was identified as a target of miR-205 in cells. The overexpression of miR-205 suppressed c-SRC and its downstream signaling molecules, including FAK, p-FAK, ERK1/2 and p-ERK1/2, and attenuated cell proliferation, invasion and tumor growth.

摘要

本研究的目的是阐明微小RNA-205(miR-205)作为前列腺癌(PCa)肿瘤抑制因子的分子机制。在本研究中,微小RNA微阵列分析表明,与早期PCa相比,晚期PCa中miR-205的表达显著降低。实时PCR分析也表明,与非癌组织相比,PCa组织中miR-205的表达显著降低。此外,已证明miR-205的表达与PCa的临床病理分期以及总/游离前列腺特异性抗原(PSA)水平相关。功能分析表明,PCa细胞系中miR-205的过表达和c-SRC的敲低均可抑制细胞生长、集落形成、迁移、侵袭以及细胞周期,并在体外诱导细胞凋亡。此外,过表达miR-205可降低体内致瘤性。通过荧光素酶活性测定和蛋白质印迹法,确定c-SRC为细胞中miR-205的靶标。miR-205的过表达抑制了c-SRC及其下游信号分子,包括FAK、p-FAK、ERK1/2和p-ERK1/2,并减弱了细胞增殖、侵袭和肿瘤生长。

相似文献

1
miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.微小RNA-205在前列腺癌中经常下调,并通过抑制肿瘤生长发挥肿瘤抑制作用。
Asian J Androl. 2013 Nov;15(6):735-41. doi: 10.1038/aja.2013.80. Epub 2013 Aug 26.
2
miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.miR-326 通过靶向黏蛋白 1 发挥抑癌作用,抑制人前列腺癌的发生。
Biomed Pharmacother. 2018 Dec;108:574-583. doi: 10.1016/j.biopha.2018.09.053. Epub 2018 Sep 20.
3
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.miR-221-5p 调节人前列腺癌细胞的增殖和迁移,并减少体内肿瘤生长。
BMC Cancer. 2019 Jun 25;19(1):627. doi: 10.1186/s12885-019-5819-6.
4
MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.miR-487a-3p 通过靶向 CCND1 在前列腺癌中发挥新的肿瘤抑制作用。
J Cell Physiol. 2020 Feb;235(2):1588-1600. doi: 10.1002/jcp.29078. Epub 2019 Jul 15.
5
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.染料木黄酮上调前列腺癌中的肿瘤抑制 microRNA-574-3p。
PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.
6
MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.微小RNA-203下调Rap1A并抑制前列腺癌细胞的增殖、黏附和侵袭。
J Exp Clin Cancer Res. 2015 Jan 31;34(1):8. doi: 10.1186/s13046-015-0125-x.
7
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.微小 RNA let-7c 在前列腺癌中下调,抑制前列腺癌生长。
PLoS One. 2012;7(3):e32832. doi: 10.1371/journal.pone.0032832. Epub 2012 Mar 30.
8
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.微小RNA-30c作为前列腺癌独立的生化复发预测指标及潜在的肿瘤抑制因子。
Mol Biol Rep. 2014 May;41(5):2779-88. doi: 10.1007/s11033-014-3132-7. Epub 2014 Jan 23.
9
MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.MicroRNA-335 在前列腺癌中作为候选肿瘤抑制因子发挥作用。
Pathol Oncol Res. 2013 Jul;19(3):529-37. doi: 10.1007/s12253-013-9613-5. Epub 2013 Mar 3.
10
MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.MicroRNA-539 通过下调 DLX1 抑制 TGF-β/Smad4 信号通路在前列腺癌中发挥肿瘤抑制作用。
J Cell Mol Med. 2019 Sep;23(9):5934-5948. doi: 10.1111/jcmm.14402. Epub 2019 Jul 12.

引用本文的文献

1
Hyperglycemia and microRNAs in prostate cancer.前列腺癌中的高血糖与微小RNA
Prostate Cancer Prostatic Dis. 2025 Mar;28(1):202-209. doi: 10.1038/s41391-024-00809-z. Epub 2024 Feb 24.
2
microRNA-205 in prostate cancer: Overview to clinical translation.微小 RNA-205 在前列腺癌中的作用:从临床前研究到临床转化。
Biochim Biophys Acta Rev Cancer. 2022 Nov;1877(6):188809. doi: 10.1016/j.bbcan.2022.188809. Epub 2022 Oct 1.
3
Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.miRNA-205 表达下调在前列腺癌肿瘤发生和骨转移中的作用及其生物学机制。
Biomed Res Int. 2020 Oct 29;2020:6037434. doi: 10.1155/2020/6037434. eCollection 2020.
4
Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.通过 CRISPR/Cas9 介导的基因敲除对前列腺癌相关 miRNA 进行功能分类。
Mol Med Rep. 2020 Nov;22(5):3777-3784. doi: 10.3892/mmr.2020.11491. Epub 2020 Sep 7.
5
miR-205: A Potential Biomedicine for Cancer Therapy.miR-205:癌症治疗的潜在生物医学。
Cells. 2020 Aug 25;9(9):1957. doi: 10.3390/cells9091957.
6
Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide.环状 RNA 在前列腺癌中表达差异,并可能与恩杂鲁胺耐药相关。
Sci Rep. 2019 Jul 24;9(1):10739. doi: 10.1038/s41598-019-47189-2.
7
Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention.血清中的五种微小RNA作为前列腺癌风险评估和治疗干预的潜在生物标志物。
Int Urol Nephrol. 2018 Dec;50(12):2193-2200. doi: 10.1007/s11255-018-2009-4. Epub 2018 Oct 15.
8
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy.微小RNA-205纳米制剂使前列腺癌细胞对化疗敏感。
Cancers (Basel). 2018 Aug 25;10(9):289. doi: 10.3390/cancers10090289.
9
MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.微小RNA-205在肝细胞癌中表达下调,并通过直接靶向血管内皮生长因子A抑制细胞生长和转移。
Oncol Lett. 2018 Aug;16(2):2207-2214. doi: 10.3892/ol.2018.8933. Epub 2018 Jun 8.
10
Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.粘着斑激酶(FAK)和脯氨酸富集酪氨酸激酶2(PYK2)的内源性调控机制及其与癌症发展的相关性。
Cancers (Basel). 2018 Jun 11;10(6):196. doi: 10.3390/cancers10060196.

本文引用的文献

1
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.miR-205 负向调控雄激素受体,与前列腺癌患者的不良预后相关。
Br J Cancer. 2013 Apr 30;108(8):1668-76. doi: 10.1038/bjc.2013.131. Epub 2013 Apr 9.
2
MicroRNAs associated with metastatic prostate cancer.与转移性前列腺癌相关的 microRNAs。
PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30.
3
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
4
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.MicroRNA-205 抑制肾癌细胞中的 Src 介导的致癌通路。
Cancer Res. 2011 Apr 1;71(7):2611-21. doi: 10.1158/0008-5472.CAN-10-3666. Epub 2011 Feb 17.
5
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.微小RNA-205介导的前列腺癌中肿瘤抑制基因的转录激活
Cancer. 2010 Dec 15;116(24):5637-49. doi: 10.1002/cncr.25488. Epub 2010 Aug 24.
6
MiR-205 silences MED1 in hypoxic primary human trophoblasts.miR-205 沉默缺氧原代人滋养层细胞中的 MED1。
FASEB J. 2010 Jun;24(6):2030-9. doi: 10.1096/fj.09-149724. Epub 2010 Jan 11.
7
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.前列腺癌中 microRNA 谱分析的诊断和预后意义。
Int J Cancer. 2010 Mar 1;126(5):1166-76. doi: 10.1002/ijc.24827.
8
microRNA-205 regulates HER3 in human breast cancer.微小RNA-205在人类乳腺癌中调控HER3。
Cancer Res. 2009 Mar 15;69(6):2195-200. doi: 10.1158/0008-5472.CAN-08-2920. Epub 2009 Mar 10.
9
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.miR-205通过下调蛋白激酶Cε在人类前列腺中发挥肿瘤抑制功能。
Cancer Res. 2009 Mar 15;69(6):2287-95. doi: 10.1158/0008-5472.CAN-08-2894. Epub 2009 Feb 24.
10
Suppression of cell growth and invasion by miR-205 in breast cancer.miR-205对乳腺癌细胞生长和侵袭的抑制作用
Cell Res. 2009 Apr;19(4):439-48. doi: 10.1038/cr.2009.18.